Company DRI Healthcare Trust

Equities

DHT.U

CA23344H1091

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
15.87 CAD -1.67% Intraday chart for DRI Healthcare Trust +0.57% +27.16%

Business Summary

DRI Healthcare Trust is a Canada-based company, which is engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It is acquiring approximately 70 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. The Company’s portfolio includes Empaveli, Eylea, Natpara, Omidria, Rydapt, Simponi, Syfovre, Vonjo, Zejula and Zytiga. Its therapeutic areas include influenza, endocrinology, ophthalmology, dermatology, oncology, neurology, autoimmune diseases, heme-onc, lysosomal storage disorder, respiratory diseases, oncology and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; Novartis; Biogen; CTI Biopharma; Roche, Novartis, Johnson & Johnson, and others.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Investment and Related Activities
100.0 %
121 100.0 % 224 100.0 % +85.30%

Sales per region

CAD in Million2022Weight2023Weight Delta
United States
77.6 %
60 53.1 % 166 77.6 % +175.84%
Rest of the World
13.7 %
22 19.0 % 29 13.7 % +35.92%
European Union
8.5 %
31 27.0 % 18 8.5 % -40.28%
Japan
0.2 %
1 0.9 % 0 0.2 % -58.98%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 20-10-20
Director of Finance/CFO - 14-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 21-01-21
Chief Executive Officer 55 20-10-20
Chairman 61 21-01-21
Director/Board Member 56 21-01-21
Director/Board Member 57 21-01-21
Director/Board Member 50 21-01-21
Director/Board Member 61 21-01-21
Director/Board Member 52 22-11-06

Shareholders

NameEquities%Valuation
Mackenzie Financial Corp.
14.99 %
8,441,267 14.99 % 90 M $
CIBC Asset Management, Inc.
10.83 %
6,100,095 10.83 % 65 M $
Dixon Mitchell Investment Counsel, Inc.
8.419 %
4,741,584 8.419 % 51 M $
DRI Capital, Inc.
2.954 %
1,663,599 2.954 % 18 M $
Manulife Investment Management Ltd.
1.768 %
995,914 1.768 % 11 M $
Franklin Bissett Investment Management
0.8536 %
480,749 0.8536 % 5 M $
Middlefield Capital Corp.
0.5060 %
285,000 0.5060 % 3 M $
I. G. Investment Management Ltd.
0.3532 %
198,922 0.3532 % 2 M $
Navin Jacob
0.2109 %
118,792 0.2109 % 1 M $
Palos Management, Inc.
0.1096 %
61,700 0.1096 % 660 807 $

Company contact information

DRI Healthcare Trust

First Canadian Place 100 King Street West

M5X 1B1, Toronto

+416-863-1865

http://www.drihealthcare.com
address DRI Healthcare Trust(DHT.U)

Group companies

NameCategory and Sector
Drug Royalty III LP
Investment Managers

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
11.73 USD
Average target price
15.16 USD
Spread / Average Target
+29.26%
Consensus